These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9922769)

  • 1. [Randomizations!].
    Piedbois P; Buyse M
    Cancer Radiother; 1998 Dec; 2(6):663-4. PubMed ID: 9922769
    [No Abstract]   [Full Text] [Related]  

  • 2. Efaproxiral (Allos Therapeutics).
    Kolman A
    IDrugs; 2003 Aug; 6(8):795-801. PubMed ID: 12917776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of concomitant chemoradiotherapy and practical recommendations].
    Bosset JF; Marty M
    Cancer Radiother; 1998 Dec; 2(6):665-7. PubMed ID: 9922770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
    Benasso M; Corvò R
    Tumori; 2008; 94(4):suppl 24-5. PubMed ID: 18822713
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining heterogeneity in phase II trial designs may improve success in phase III.
    Tuma RS
    J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
    [No Abstract]   [Full Text] [Related]  

  • 6. [Concomitant chemoradiotherapy of infiltrating cancers of the bladder].
    Housset M
    Cancer Radiother; 1998 Dec; 2(6):713-7. PubMed ID: 9922778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of radiation and chemotherapy.
    Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F
    Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cisplatin and derivatives with radiation therapy: for what clinical use?].
    Durdux C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S88-94. PubMed ID: 15679253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
    Milas L; Gregoire V; Hunter N; Kurdoglu B; Mason K; Meyn R
    Adv Exp Med Biol; 1997; 400B():559-64. PubMed ID: 9547604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local control of the primary tumor. Necessary step in control of cancer].
    Gérard JP; Roy P; Cucherat M
    Cancer Radiother; 1998 Dec; 2(6):668-71. PubMed ID: 9922771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitizing action of ametohepazon on the irradiated tumor tissues. II. Preliminary clinical report.
    Niibe H; Tobe T; Kato T; Hirai E; Toda N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):995-1006. PubMed ID: 5245253
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in combined modality therapy.
    Mierzwa ML; Nyati MK; Morgan MA; Lawrence TS
    Oncologist; 2010; 15(4):372-81. PubMed ID: 20413642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined curietherapy and chemotherapy].
    Mazeron JJ
    Cancer Radiother; 1998 Dec; 2(6):781-2. PubMed ID: 9922788
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined chemotherapy and radiation for locally advanced cervical carcinoma.
    Bridgewater J
    Clin Oncol (R Coll Radiol); 1998; 10(2):78-83. PubMed ID: 9610895
    [No Abstract]   [Full Text] [Related]  

  • 16. SOP 09: Statistical design and analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():43-7. PubMed ID: 23570186
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical chemosensitization by misonidazole and related compounds: a critical evaluation.
    Mulcahy RT; Trump DL
    J Clin Oncol; 1988 Apr; 6(4):569-73. PubMed ID: 3357002
    [No Abstract]   [Full Text] [Related]  

  • 18. Response evaluation: beyond RECIST.
    Eisenhauer EA
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix29-32. PubMed ID: 17631592
    [No Abstract]   [Full Text] [Related]  

  • 19. Why do phase III clinical trials in oncology fail so often?
    Amiri-Kordestani L; Fojo T
    J Natl Cancer Inst; 2012 Apr; 104(8):568-9. PubMed ID: 22491346
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer.
    Millar BC
    Biochem Pharmacol; 1982 Aug; 31(15):2439-45. PubMed ID: 6751333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.